0.9363
0.68%
0.0063
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
86.84%
0.4679
|
3.5552 | 2.4571 | 0.1978 | 0.602 |
Cost Of Revenue |
92.10%
0.2345
|
2.9678 | 0.2558 | 0.4591 | 0.5022 |
Gross Profit |
60.27%
0.2333
|
0.5873 | 2.2013 | -0.2613 | 0.0997 |
Operating Expenses
|
15.47%
10.49
|
12.41 | 11.14 | 11.73 | 10.05 |
Benefits Costs and Expenses |
32.23%
9.7571
|
14.40 | 10.55 | 11.35 | 8.6172 |
Costs And Expenses |
32.23%
9.7571
|
14.40 | 10.55 | 11.35 | 8.6172 |
Depreciation and Amortization |
5.66%
0.3306
|
0.3129 | 0.2963 | 0.3052 | 0.316 |
Operating Income/Loss |
13.24%
-10.26
|
-11.83 | -8.936 | -11.99 | -9.9507 |
Nonoperating Income/Loss |
1.29%
0.9701
|
0.9828 | 0.8402 | 0.8373 | 1.9354 |
Income/Loss From Continuing Operations Before Tax |
14.32%
-9.2893
|
-10.84 | -8.0958 | -11.16 | -8.0152 |
Income Tax Expense/Benefit |
99.41%
0.0228
|
3.834 | -2.1136 | -2.2383 | -2.2598 |
Income/Loss From Continuing Operations After Tax |
36.55%
-9.312
|
-14.68 | -5.9822 | -8.9188 | -5.7554 |
Net Income/Loss
|
36.55%
-9.312
|
-14.68 | -5.9822 | -8.9188 | -5.7554 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
74,457%
29.84
|
0.04 | 29.36 | 29.09 | 29.48 |
Diluted Average Shares |
74,457%
29.84
|
0.04 | 29.36 | 29.09 | 29.48 |
Basic Earnings Per Share |
38.00%
-0.31
|
-0.50 | -0.20 | -0.31 | -0.20 |
Diluted Earnings Per Share |
38.00%
-0.31
|
-0.50 | -0.20 | -0.31 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):